Skip to main content

Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM

Financial updates

Pharming Group N.V. announces the publication of its Annual Report for the year ended 31 December 2020. In addition, the Company’s 2021 Annual General Meeting (AGM) will be held at 16:00CET on Wednesday, 19 May 2021. The Notice to Convene, Explanatory Notes, meeting documents and Form of Proxy can be found on the Company’s website, under Investors/Shareholders’ Meetings.

Read more

Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ordinary Shares on Nasdaq Global Market

Financial updates

Pharming Group N.V., a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs, today announces that it has publicly filed a registration statement with the U.S. Securities and Exchange Commission (the "SEC") in connection with a proposed listing of American Depositary Shares ("ADSs") representing the Company's ordinary shares of nominal value €0.01 each ("Ordinary Shares") on the Nasdaq Global Market ("Nasdaq").

Read more

Filters

  • Cookies: This website uses cookies Check the cookies page for more information Accept Decline